[{"address1": "201 Brookline Avenue", "address2": "Suite 901", "city": "Boston", "state": "MA", "zip": "02215", "country": "United States", "phone": "857 320 4900", "website": "https://www.tangotx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase 11 loss-of-function mutations for treating lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 155, "companyOfficers": [{"maxAge": 1, "name": "Dr. Barbara L. Weber M.D.", "age": 67, "title": "Founder & Executive Chair", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 1125489, "exercisedValue": 0, "unexercisedValue": 657452}, {"maxAge": 1, "name": "Dr. Malte  Peters M.D.", "age": 63, "title": "President, CEO & Director", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 51500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Daniella  Beckman CPA", "age": 46, "title": "Chief Financial Officer", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 717616, "exercisedValue": 0, "unexercisedValue": 337565}, {"maxAge": 1, "name": "Mr. Douglas J. Barry Esq., J.D.", "age": 55, "title": "Chief Compliance Officer & Corporate Secretary", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 674222, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Adam S. Crystal M.D., Ph.D.", "age": 48, "title": "President of Research & Development", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 882167, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Alan  Ashworth FRS, Ph.D.", "age": 64, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1961, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William G. Kaelin Jr., M.D.", "age": 67, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Antoni  Ribas M.D., Ph.D.", "age": 57, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Palmieri Ph.D.", "title": "Chief Technical Operations Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jannik N. Andersen Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 4, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 12.35, "open": 12.22, "dayLow": 11.7, "dayHigh": 12.53, "regularMarketPreviousClose": 12.35, "regularMarketOpen": 12.22, "regularMarketDayLow": 11.7, "regularMarketDayHigh": 12.53, "payoutRatio": 0.0, "beta": 1.754, "forwardPE": -9.047432, "volume": 1568350, "regularMarketVolume": 1568350, "averageVolume": 3084036, "averageVolume10days": 3765330, "averageDailyVolume10Day": 3765330, "bid": 11.64, "ask": 11.89, "bidSize": 48, "askSize": 48, "marketCap": 1577068672, "fiftyTwoWeekLow": 1.03, "fiftyTwoWeekHigh": 13.46, "allTimeHigh": 18.84, "allTimeLow": 1.03, "priceToSalesTrailing12Months": 23.714962, "fiftyDayAverage": 9.7524, "twoHundredDayAverage": 6.50375, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1458047744, "profitMargins": -1.51148, "floatShares": 80160147, "sharesOutstanding": 134677094, "sharesShort": 39972307, "sharesShortPriorMonth": 33248529, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.29680002, "heldPercentInsiders": 0.04952, "heldPercentInstitutions": 0.97475, "shortRatio": 15.73, "shortPercentOfFloat": 0.3441, "impliedSharesOutstanding": 134677094, "bookValue": 1.434, "priceToBook": 8.165969, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -100515000, "trailingEps": -0.91, "forwardEps": -1.29429, "enterpriseToRevenue": 21.925, "enterpriseToEbitda": -13.511, "52WeekChange": 2.8267975, "SandP52WeekChange": 0.15024745, "quoteType": "EQUITY", "currentPrice": 11.71, "targetHighPrice": 15.0, "targetLowPrice": 12.0, "targetMeanPrice": 13.625, "targetMedianPrice": 14.0, "recommendationMean": 1.3, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 152811008, "totalCashPerShare": 1.135, "ebitda": -107913000, "totalDebt": 34763000, "quickRatio": 8.285, "currentRatio": 8.88, "totalRevenue": 66501000, "debtToEquity": 21.723, "revenuePerShare": 0.602, "returnOnAssets": -0.24517, "returnOnEquity": -0.51652, "grossProfits": -67500000, "freeCashflow": -62384376, "operatingCashflow": -145815008, "revenueGrowth": 3.636, "grossMargins": -1.01502, "ebitdaMargins": -1.6227299, "operatingMargins": 0.26150998, "financialCurrency": "USD", "symbol": "TNGX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1599139800000, "postMarketChangePercent": 0.00085513067, "postMarketPrice": 11.7101, "postMarketChange": 0.0001001358, "regularMarketChange": -0.64, "regularMarketDayRange": "11.7 - 12.53", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 3084036, "fiftyTwoWeekLowChange": 10.68, "fiftyTwoWeekLowChangePercent": 10.368933, "fiftyTwoWeekRange": "1.03 - 13.46", "fiftyTwoWeekHighChange": -1.75, "fiftyTwoWeekHighChangePercent": -0.13001485, "fiftyTwoWeekChangePercent": 282.67975, "corporateActions": [], "postMarketTime": 1769213052, "regularMarketTime": 1769202001, "exchange": "NGM", "messageBoardId": "finmb_424111353", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -5.18219, "regularMarketPrice": 11.71, "shortName": "Tango Therapeutics, Inc.", "longName": "Tango Therapeutics, Inc.", "marketState": "CLOSED", "earningsTimestamp": 1762263000, "earningsTimestampStart": 1762263000, "earningsTimestampEnd": 1762263000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.91, "epsForward": -1.29429, "epsCurrentYear": -0.89875, "priceEpsCurrentYear": -13.029207, "fiftyDayAverageChange": 1.9575996, "fiftyDayAverageChangePercent": 0.20073003, "twoHundredDayAverageChange": 5.20625, "twoHundredDayAverageChangePercent": 0.80049974, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "displayName": "Tango Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-24"}]